Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years
Not Applicable
Terminated
- Conditions
- Hepatitis B Vaccination
- Registration Number
- NCT02166671
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
This study will evaluate the humoral and cellular immune responses to a hepatitis B vaccine booster in healthy adults which received a full course of neonatal hepatitis B vaccination 20-23 years ago.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
- healthy adults 20-25 years old
Exclusion Criteria
- Hepatitis B surface antigen (+)
- Hepatitis B core antibody (+)
- any history of liver disorders including hepatitis
- HIV Ag or Ab(+)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method change of HBsAb titer 28 days after HBV booster vaccination
- Secondary Outcome Measures
Name Time Method HBsAg-specific cell mediated immunity 28 days after HBV booster vaccination
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Seoul National University Hospital🇰🇷Seoul, Korea, Republic of